FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a method for preparing 1-(3-(2-(1-benzothiophene-5-yl)ethoxy)propyl)azetidine-3-ol or its salts which involves the use as a parent compound, (phenylthio)acetic acid derivative or its salts presented by general formula: 
where X1 represents halogen atom, and is applicable as a safe method of volume production of 1-(3-(2-(1-benzothiophene-5-yl)ethoxy)propyl)azetidine-3-ol or its salts effective as an agent in disorders of the central nervous system and peripheral nervous system.
EFFECT: there is provided high yield, safety for human body, low environment loads.
36 cl, 1 tbl, 33 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING 3-[5-[4-(CYCLOPENTYLOXY)-2-HYDROXYBENZOYL]-2-[(3-OXO-2-SUBSTITUTED-2, 3-DIHYDRO-1, 2-BENZISOXAZOL-6-YL)METHOXY]PHENYL]PROPIONIC ACID ESTER AND INTERMEDIATE PRODUCT FOR SAID METHOD | 2007 |
|
RU2434002C2 |
| METHOD OF SYNTHESIS OF DERIVATIVES OF 5-HYDROXY-BENZO[B]THIOPHENE-3- CARBOXYLIC ACID (VARIANTS) AND THIOPHENIC ACID DERIVATIVES | 1999 |
|
RU2186065C1 |
| METHOD OF PRODUCING 2-[1-ETHYLSULPHONYL-3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PYRAZOL-1-YL]AZETIDIN-3-YL]ACETONITRILE | 2024 |
|
RU2835441C1 |
| METHOD OF PRODUCING 2-[1-ETHYLSULPHONYL-3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PYRAZOL-1-YL]AZETIDIN-3-YL]ACETONITRILE | 2024 |
|
RU2835443C1 |
| METHOD OF PRODUCING 2-[1-ETHYLSULPHONYL-3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PYRAZOL-1-YL]AZETIDIN-3-YL]ACETONITRILE | 2024 |
|
RU2835445C1 |
| METHODS FOR PREPARATION OF (S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHANESULFONYLETHYLAMINE | 2013 |
|
RU2632875C2 |
| HETEROCYCLIC COMPOUND | 2006 |
|
RU2382781C2 |
| METHODS OF PRODUCING HEXAHYDROFURO[2, 3-b] FURAN-3-OL | 2007 |
|
RU2464266C2 |
| 1-SUBSTITUTED 4-NITROIMIDAZOLE DERIVATIVE AND METHOD OF ITS PRODUCTION | 2003 |
|
RU2324682C2 |
| 1-HETEROCYCLYLSULPHONYL, 2-AMINOMETHYL, 5-(HETERO)ARYL SUBSTITUTED 1-H-PYRROLE DERIVATIVES AS ACID SECRETION INHIBITORS | 2006 |
|
RU2415838C2 |
